Stock exchange news | Navamedic

Read the latest news directly from the market.

Navamedic ASA: Record high quarter with above 50 percent growth

The company’s gross margin was 37.6 per cent, down from 42.5 per cent in the third quarter of 2022. Adjusted Read more

Navamedic ASA: Invitation to 2023 3rd quarter presentation

Oslo, October 27, 2023 - Navamedic ASA (OSE: Nava) will be presenting its third quarter 2023 results on Wednesday, November Read more

Navamedic ASA: Significant growth across the business

For the first half of 2023, the gross margin was 40.9 per cent, down from 42.9 per cent last year. Read more

Navamedic ASA: Invitation to 2023 2nd quarter presentation

Oslo, August 7, 2023 - Navamedic ASA (OSE: Nava) will be presenting its second quarter 2023 results and publish its Read more

Navamedic ASA: Annual Report for 2022

The report is attached to this notice and is available at navamedic.com/investors. In addition, the company has published its annual Read more

Navamedic ASA: Amended cash offer to acquire Sensidose AB and acquisition of shares in Sensidose AB

Navamedic ASA ("Navamedic") has today amended its Offer to SEK 8.00 per share in Sensidose AB ("Sensidose") representing a total Read more

Navamedic ASA: Recommended cash offer to acquire Sensidose for approximately SEK 75 million

Sensidose is a Sweden-based pharmaceutical company that sells drugs in combination with an innovative device for individual dosing, targeting patients Read more

Navamedic ASA: Q4 2022 financial results

“The fourth quarter completed an eventful year for Navamedic. Product launches, increased campaign activities and M&A agreements can summarise the Read more

Subscribe to stock exhange news